Research progress of spinal muscular atrophy treatment in children

Spinal muscular atrophy (SMA) is the most common fatal neurogenetic disease in infant period. Clinical manifestations of SMA include symmetrical and progressive weakness and atrophy of proximal limbs. Based on age of incidence, it is divided into child-onset SMA and adult-onset SMA. Child-onset SMA...

Full description

Bibliographic Details
Main Authors: Miao ZHAO, Ying-qian LU, Ning WANG, Wan-jin CHEN
Format: Article
Language:English
Published: Tianjin Huanhu Hospital 2018-04-01
Series:Chinese Journal of Contemporary Neurology and Neurosurgery
Subjects:
Online Access:http://www.cjcnn.org/index.php/cjcnn/article/view/1769
_version_ 1818151448467210240
author Miao ZHAO
Ying-qian LU
Ning WANG
Wan-jin CHEN
author_facet Miao ZHAO
Ying-qian LU
Ning WANG
Wan-jin CHEN
author_sort Miao ZHAO
collection DOAJ
description Spinal muscular atrophy (SMA) is the most common fatal neurogenetic disease in infant period. Clinical manifestations of SMA include symmetrical and progressive weakness and atrophy of proximal limbs. Based on age of incidence, it is divided into child-onset SMA and adult-onset SMA. Child-onset SMA has the highest incidence rate. This article summarizes the research progress of SMA therapy in recent years to provide new thoughts for the treatment of SMA. DOI: 10.3969/j.issn.1672-6731.2018.04.010
first_indexed 2024-12-11T13:38:59Z
format Article
id doaj.art-fe2bb63c6bd04d8084a41edeb52bd2f0
institution Directory Open Access Journal
issn 1672-6731
language English
last_indexed 2024-12-11T13:38:59Z
publishDate 2018-04-01
publisher Tianjin Huanhu Hospital
record_format Article
series Chinese Journal of Contemporary Neurology and Neurosurgery
spelling doaj.art-fe2bb63c6bd04d8084a41edeb52bd2f02022-12-22T01:04:53ZengTianjin Huanhu HospitalChinese Journal of Contemporary Neurology and Neurosurgery1672-67312018-04-0118428428910.3969/j.issn.1672-6731.2018.04.0101724Research progress of spinal muscular atrophy treatment in childrenMiao ZHAO0Ying-qian LU1Ning WANG2Wan-jin CHEN3Department of Neurology, the First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, Fujian, ChinaDepartment of Neurology, the First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, Fujian, ChinaDepartment of Neurology, the First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, Fujian, ChinaDepartment of Neurology, the First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, Fujian, ChinaSpinal muscular atrophy (SMA) is the most common fatal neurogenetic disease in infant period. Clinical manifestations of SMA include symmetrical and progressive weakness and atrophy of proximal limbs. Based on age of incidence, it is divided into child-onset SMA and adult-onset SMA. Child-onset SMA has the highest incidence rate. This article summarizes the research progress of SMA therapy in recent years to provide new thoughts for the treatment of SMA. DOI: 10.3969/j.issn.1672-6731.2018.04.010http://www.cjcnn.org/index.php/cjcnn/article/view/1769Spinal muscular atrophies of childhoodGenesReview
spellingShingle Miao ZHAO
Ying-qian LU
Ning WANG
Wan-jin CHEN
Research progress of spinal muscular atrophy treatment in children
Chinese Journal of Contemporary Neurology and Neurosurgery
Spinal muscular atrophies of childhood
Genes
Review
title Research progress of spinal muscular atrophy treatment in children
title_full Research progress of spinal muscular atrophy treatment in children
title_fullStr Research progress of spinal muscular atrophy treatment in children
title_full_unstemmed Research progress of spinal muscular atrophy treatment in children
title_short Research progress of spinal muscular atrophy treatment in children
title_sort research progress of spinal muscular atrophy treatment in children
topic Spinal muscular atrophies of childhood
Genes
Review
url http://www.cjcnn.org/index.php/cjcnn/article/view/1769
work_keys_str_mv AT miaozhao researchprogressofspinalmuscularatrophytreatmentinchildren
AT yingqianlu researchprogressofspinalmuscularatrophytreatmentinchildren
AT ningwang researchprogressofspinalmuscularatrophytreatmentinchildren
AT wanjinchen researchprogressofspinalmuscularatrophytreatmentinchildren